Correlation Between Sonnet Biotherapeutics and Bright Minds

Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Bright Minds Biosciences, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Bright Minds.

Diversification Opportunities for Sonnet Biotherapeutics and Bright Minds

-0.64

Correlation Coefficient

Sonnet Biotherapeutics  Bright Minds

Excellent diversification

The 3 months correlation between Sonnet and Bright is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Bright Minds go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Bright Minds

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to generate 0.95 times more return on investment than Bright Minds. However, Sonnet Biotherapeutics Holdings is 1.06 times less risky than Bright Minds. It trades about -0.08 of its potential returns per unit of risk. Bright Minds Biosciences is currently generating about -0.19 per unit of risk. If you would invest  203.00  in Sonnet Biotherapeutics Holdings on February 7, 2024 and sell it today you would lose (17.00) from holding Sonnet Biotherapeutics Holdings or give up 8.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sonnet Biotherapeutics Holding  vs.  Bright Minds Biosciences

Sonnet Biotherapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Sonnet Biotherapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Bright Minds Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bright Minds Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Sonnet Biotherapeutics and Bright Minds

The main advantage of trading using opposite Sonnet Biotherapeutics and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.

The idea behind Sonnet Biotherapeutics Holdings and Bright Minds Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.